Funded Startups in New Albany
Among the five most recent funded entries tied to New Albany, the largest disclosed round is RxLightning’s $18M Series A on 2023-06-06, which sits well abo…
Among the five most recent funded entries tied to New Albany, the largest disclosed round is RxLightning’s $18M Series A on 2023-06-06, which sits well above the rest of the disclosed amounts (the next-largest disclosed figure is $1M for PolyGroup on 2022-06-22, with two smaller disclosed rounds at $10K and $100K). Two date clusters stand out: three rounds fell within about two weeks in June 2023 (Hope Southern Indiana on 2023-07-12; One Southern Indiana on 2023-06-15; RxLightning on 2023-06-06), while the remaining disclosed rounds stretch back to 2022 (PolyGroup on 2022-06-22 and Feazel on 2022-03-17). Sector mix is narrow at the top: Information Technology and Biotechnology each appear once with disclosed funding ($18M and $1M), and the majority of rows fall under “Series Unknown” or similar labeling (including one “undisclosed” amount). Geographically, four rows list New Albany, Indiana, and one row lists New Albany, Ohio, which helps explain why the list is spread across state lines rather than a single-city concentration within one geography. The shown window runs from 2022-03-17 (Feazel) through 2023-07-12 (Hope Southern Indiana).
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the biggest disclosed round in this New Albany slice, and how does it compare to the next disclosed amounts?
RxLightning’s $18M Series A (2023-06-06) is the only disclosed amount in the list above $1M and dwarfs the next-largest disclosed figure: PolyGroup’s $1M on 2022-06-22. The other disclosed rounds are much smaller ($10K on 2023-07-12 for Hope Southern Indiana, and $100K on 2022-03-17 for Feazel).
Do the most recent deals cluster into a narrow time window?
Yes. Three of the five entries have June/July 2023 close dates—RxLightning on 2023-06-06, One Southern Indiana on 2023-06-15, and Hope Southern Indiana on 2023-07-12—creating a June 2023 concentration relative to the 2022 rounds (PolyGroup on 2022-06-22 and Feazel on 2022-03-17).
How often are amounts or stages not clearly disclosed, and what does that imply for stage comparability?
Three of five rows don’t provide a comparable disclosed amount by the table’s values: One Southern Indiana is marked “undisclosed” (2023-06-15), and two others use non-standard stage labels (“Series Unknown” for Hope Southern Indiana on 2023-07-12, and “Venture - Series Unknown” for PolyGroup on 2022-06-22). Only RxLightning (Series A, $18M on 2023-06-06) and Feazel (Private Equity, $100K on 2022-03-17) provide both an explicit stage label and a disclosed amount.
Is New Albany represented consistently by state, or split across geographies?
It’s split across state lines: four rows are for New Albany, Indiana (Hope Southern Indiana 2023-07-12; One Southern Indiana 2023-06-15; RxLightning 2023-06-06; PolyGroup 2022-06-22), while Feazel lists New Albany, Ohio (2022-03-17).
Are there sector skews among the disclosed rounds shown?
Among the two largest disclosed deals, the sectors differ: RxLightning is Information Technology with $18M (2023-06-06) and PolyGroup is Biotechnology with $1M (2022-06-22). The remaining disclosed entries are Professional Services ($100K for Feazel, 2022-03-17) and an “Other” category ($10K for Hope Southern Indiana, 2023-07-12), with one additional row having an “undisclosed” amount in Community and Lifestyle (One Southern Indiana, 2023-06-15).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.